(Q30521394)

12 August 2017

Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1) (English)

1 reference

12 August 2017

1 reference

1 reference

Chad Heatwole

1

1 reference

12 August 2017

Rita Bode

2

1 reference

12 August 2017

Nicholas Johnson

3

1 reference

12 August 2017

Christine Quinn

4

1 reference

12 August 2017

William Martens

5

1 reference

12 August 2017

Michael P McDermott

6

1 reference

12 August 2017

Nan Rothrock

7

1 reference

12 August 2017

Charles Thornton

8

1 reference

12 August 2017

Barbara Vickrey

9

1 reference

12 August 2017

David Victorson

10

1 reference

12 August 2017

Richard Moxley

11

1 reference

12 August 2017

language of work or name

English

0 references

publication date

11 July 2012

1 reference

12 August 2017

1 reference

12 August 2017

79

1 reference

12 August 2017

4

1 reference

12 August 2017

348-357

1 reference

If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

High disease impact of myotonic dystrophy type 2 on physical and mental functioning

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

Health supervision and anticipatory guidance in adult myotonic dystrophy type 1.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

Myotonic dystrophy: the burden for patients and their partners

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

Patient-reported outcomes to support medical product labeling claims: FDA perspective

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

Prevalence of irritable bowel syndrome: a community survey

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

An unstable triplet repeat in a gene related to myotonic muscular dystrophy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

The Patient-Centered Outcomes Research Institute--promoting better information, decisions, and health.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

The correlation of CTG repeat length with material and social deprivation in myotonic dystrophy.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

Challenges in drug development for muscle disease: a stakeholders' meeting.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400095

New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC)

26 November 2018

1 reference

12 December 2020

Criteria for establishing the validity of genetic recombination in myotonic dystrophy

1 reference

12 December 2020

Outcomes measurement: a report from the front

1 reference

12 December 2020

Unstable DNA sequence in myotonic dystrophy

1 reference

12 December 2020

Prediction of myotonic dystrophy clinical severity based on the number of intragenic [CTG]n trinucleotide repeats

1 reference

12 December 2020

Genotype-phenotype correlation in myotonic dystrophy

1 reference

12 December 2020

Patient-reported outcomes: instrument development and selection issues

1 reference

12 December 2020

What is sufficient evidence for the reliability and validity of patient-reported outcome measures?

1 reference

12 December 2020

Clinical and Genetic Knowledge and Attitudes of Patients with Myotonic Dystrophy Type 1

1 reference

12 December 2020

10.1212/WNL.0B013E318260CBE6

Identifiers

DOI

1 reference

release_3v7ourqvyvbzrgu4asgyug3p6a

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3v7ourqvyvbzrgu4asgyug3p6a

24 November 2022

mapped directly with Wikidata item

1 reference

12 August 2017

PubMed publication ID

22786587

1 reference